22:14 , Oct 2, 2018 |  BC Extra  |  Company News

Management tracks: Synlogic, Trevena, Editas

Synlogic Inc. (NASDAQ:SYBX) promoted Aoife Brennan to president and CEO. She has held both positions on an interim basis since May, when former President and CEO Jose Carlos Gutiérrez-Ramos resigned. Brennan had been CMO of...
21:36 , Dec 15, 2017 |  BC Week In Review  |  Financial News

Bellus Health raises C$20M in follow-on

On Dec. 12, Bellus Health Inc. (TSX:BLU) raised C$20 million ($15.6 million) through the sale of 52.6 million shares at C$0.38 in a follow-on. The price values the company at C$45.4 million ($35.4 million). Bloom...
19:41 , Jun 23, 2017 |  BC Week In Review  |  Financial News

Antibe closes C$4 million follow-on

On June 21, pain and inflammation company Antibe Therapeutics Inc. (TSX-V:ATE; OTCQX:ATBPF) raised C$4 million ($3.1 million) through the sale of 40.5 million units at C$0.10 in the first close of a follow-on. Bloom Burton,...
19:11 , Jun 23, 2017 |  BC Week In Review  |  Financial News

Resverlogix completes private placement and overnight marketed equity offering

Resverlogix Corp. (TSX:RVX) raised C$9.9 million ($7.5 million) through the sale of 5.5 million units at C$1.80 in a two-part offering which closed on June 20. Resverlogix sold 3 million units to existing investors Eastern...
16:25 , Mar 17, 2017 |  BC Week In Review  |  Company News

Medicenna goes public

Cancer company Medicenna Therapeutics Inc. went public via the acquisition of Canadian capital pool company A2 Acquisition Corp. A2 shareholders received one share in the newco for every 14 A2 shares held. Prior to the...
21:58 , Dec 30, 2016 |  BC Week In Review  |  Financial News

Knight Therapeutics completes follow-on

Knight raised C$100 million ($74.9 million) through the sale of 10 million shares at C$10 in a follow-on underwritten by GMP Securities, Cormark Securities, Bloom Burton, CIBC World Markets, Laurentian Bank Securities, Mackie Research Capital,...
21:31 , Dec 2, 2016 |  BioCentury  |  Emerging Company Profile

Passing CARs

CAR T therapies have produced profound responses in hematological cancers, but also severe toxicities such as cytokine release syndrome. Triumvira Immunologics Inc. ’s T Cell-Antigen Coupler platform combines the specificity of chimeric antigen receptors with...
08:00 , Jan 4, 2016 |  BC Week In Review  |  Financial News

Antibe Therapeutics completes private placement of senior convertible debentures

Antibe Therapeutics Inc. (TSX-V:ATE), Hamilton, Ontario   Business: Inflammation, Neurology, Autoimmune   Date completed: 2015-12-24   Type: Private placement of senior convertible debentures   Raised: C$450,000 ($323,145)   Shares outstanding prior: 75.7 million   Placement...
07:00 , Oct 26, 2015 |  BC Week In Review  |  Financial News

Antibe Therapeutics completes private placement of senior convertible debentures

Antibe Therapeutics Inc. (TSX-V:ATE), Hamilton, Ontario   Business: Inflammation, Neurology, Autoimmune   Date completed: 2015-10-16   Type: Private placement of senior convertible debentures   Raised: C$1.8 million ($1.4 million)   Shares outstanding prior: 49.7 million...
07:00 , Jun 15, 2015 |  BC Week In Review  |  Financial News

Medicure proposes follow-on

Medicure Inc. (TSX-V:MPH; OTCQB:MCUJF), Winnipeg, Manitoba   Business: Cardiovascular   Date announced: 2015-06-10   Type: Follow-on   To be raised: Up to C$3.5 million ($2.8 million)   Shares: 1.6 million   Price: C$2.20   Underwriters:...